20th Regulatory Affairs and Pharmacovigilance Virtual Conference
This edition of the 20th Regulatory Affairs and Pharmacovigilance Conference consists of a total of 6 virtual sessions that will be spread over 2 weeks from 19 January until 2 February 2021.
Remco Munnik, Associate Director of Iperion Life Sciences Consultancy and chair of the Telematics Board will co-host the 2nd session: Digitalisation and operational excellence in the pharmaceutical strategy.
This session will be a dialogue between industry and regulators on how digitalization can support the regulatory objectives in the pharmaceutical strategy and what the concrete next steps are towards a coherent data strategy as a foundation to respond to public health needs.
Session: Digitalisation and operational excellence in the pharmaceutical strategy
Date: 21 January, 2021 / 14:00-15:30 CET
Remco Munnik – Iperion
Britt Vermeij – TEVA
Hilmar Hamann – Head of Information Management Division, EMA
Harald von Aschen – Chair of the IT Directors Executive Committee
Joris Kampmeijer – Chief Information Officer, MEB (NL)
Peter Bachmann – European Union and International Affairs, BfArM (DE)
Georg Neuwirther – Head of IT, AGES (IT)
Session 1: Looking to the future – Horizon 2025
Session 2: Digitalisation and operational excellence in the pharmaceutical strategy
Session 3: Resilience of the supply chain: Dependency of third counties?
Session 4: Future quality systems
Session 5: Pharmacovigilance in 2021: What can we expect?
Session 6: Life must continue after Brexit – Operating in the post-Brexit regulatory environment